These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 21497210)

  • 1. Comparison of outcomes for patients receiving drug-eluting versus bare metal stents for non-ST-segment elevation myocardial infarction.
    Hannan EL; Samadashvili Z; Walford G; Holmes DR; Jacobs AK; Stamato NJ; Venditti FJ; Sharma S; Fergus I; King SB
    Am J Cardiol; 2011 May; 107(9):1311-8. PubMed ID: 21497210
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Meta-analysis of long-term outcomes for drug-eluting stents versus bare-metal stents in primary percutaneous coronary interventions for ST-segment elevation myocardial infarction.
    Wallace EL; Abdel-Latif A; Charnigo R; Moliterno DJ; Brodie B; Matnani R; Ziada KM
    Am J Cardiol; 2012 Apr; 109(7):932-40. PubMed ID: 22221949
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of six-month outcomes for primary percutaneous revascularization for acute myocardial infarction with drug-eluting versus bare metal stents (from the APEX-AMI study).
    Patel MR; Pfisterer ME; Betriu A; Widmisky P; Holmes DR; O'Neill WW; Stebbins A; Van de Werf F; Armstrong PW; Granger CB;
    Am J Cardiol; 2009 Jan; 103(2):181-6. PubMed ID: 19121433
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drug-eluting or bare-metal stents for acute myocardial infarction.
    Mauri L; Silbaugh TS; Garg P; Wolf RE; Zelevinsky K; Lovett A; Varma MR; Zhou Z; Normand SL
    N Engl J Med; 2008 Sep; 359(13):1330-42. PubMed ID: 18815397
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Paclitaxel-eluting stents versus bare-metal stents in acute myocardial infarction.
    Stone GW; Lansky AJ; Pocock SJ; Gersh BJ; Dangas G; Wong SC; Witzenbichler B; Guagliumi G; Peruga JZ; Brodie BR; Dudek D; Möckel M; Ochala A; Kellock A; Parise H; Mehran R;
    N Engl J Med; 2009 May; 360(19):1946-59. PubMed ID: 19420364
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drug-eluting stents are associated with similar cardiovascular outcomes when compared to bare metal stents in the setting of acute myocardial infarction.
    Slottow TL; Steinberg DH; Roy P; Javaid A; Buch AN; Okabe T; Xue Z; Smith K; Torguson R; Pichard AD; Satler LF; Suddath WO; Kent KM; Waksman R
    Cardiovasc Revasc Med; 2008; 9(1):24-8. PubMed ID: 18206634
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of three-year clinical outcome of sirolimus- and paclitaxel-eluting stents versus bare metal stents in patients with ST-segment elevation myocardial infarction (from the RESEARCH and T-SEARCH Registries).
    Daemen J; Tanimoto S; García-García HM; Kukreja N; van de Sande M; Sianos G; de Jaegere PP; van Domburg RT; Serruys PW
    Am J Cardiol; 2007 Apr; 99(8):1027-32. PubMed ID: 17437722
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of safety and efficacy of sirolimus-eluting stents versus bare metal stents in patients with ST-segment elevation myocardial infarction.
    Newell MC; Henry CR; Sigakis CJ; Unger BT; Larson DM; Chavez IJ; Burke MN; Traverse JH; Henry TD
    Am J Cardiol; 2006 May; 97(9):1299-302. PubMed ID: 16635599
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical outcome after primary percutaneous coronary intervention with drug-eluting and bare metal stents in patients with ST-segment elevation myocardial infarction.
    Jensen LO; Maeng M; Thayssen P; Kaltoft A; Tilsted HH; Bøttcher M; Lassen JF; Hansen KN; Krusell LR; Rasmussen K; Pedersen KE; Pedersen L; Paaske Johnsen S; Sørensen HT; Thuesen L
    Circ Cardiovasc Interv; 2008 Dec; 1(3):176-84. PubMed ID: 20031676
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of five-year outcome of octogenarians undergoing percutaneous coronary intervention with drug-eluting versus bare-metal stents (from the RESEARCH and T-SEARCH Registries).
    Cheng JM; Onuma Y; Piazza N; Nuis RJ; Van Domburg RT; Serruys PW;
    Am J Cardiol; 2010 Nov; 106(10):1376-81. PubMed ID: 21059424
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gender-based outcomes in percutaneous coronary intervention with drug-eluting stents (from the National Heart, Lung, and Blood Institute Dynamic Registry).
    Abbott JD; Vlachos HA; Selzer F; Sharaf BL; Holper E; Glaser R; Jacobs AK; Williams DO;
    Am J Cardiol; 2007 Mar; 99(5):626-31. PubMed ID: 17317361
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of effectiveness of bare metal stents versus drug-eluting stents in large (> or =3.5 mm) coronary arteries.
    Steinberg DH; Mishra S; Javaid A; Slottow TL; Buch AN; Roy P; Okabe T; Smith KA; Torguson R; Xue Z; Pichard AD; Satler LF; Kent KM; Suddath WO; Waksman R
    Am J Cardiol; 2007 Mar; 99(5):599-602. PubMed ID: 17317356
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Paclitaxel-eluting versus bare-metal stents in acute ST elevation myocardial infarction (STEMI).
    Hamirani YS; Jibrin I; Abraham D; Merriman B; Wenz C; Bahr RD
    Crit Pathw Cardiol; 2008 Dec; 7(4):232-8. PubMed ID: 19050419
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical outcomes after sirolimus-eluting, paclitaxel-eluting, and bare metal stents (from the first phase of the prospective multicenter German DES.DE Registry).
    Nienaber CA; Akin I; Schneider S; Senges J; Fetsch T; Tebbe U; Willich SN; Stumpf J; Sabin GV; Silber S; Richardt G; Kuck KH;
    Am J Cardiol; 2009 Nov; 104(10):1362-9. PubMed ID: 19892051
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of mortality rates in women versus men presenting with ST-segment elevation myocardial infarction.
    D'Ascenzo F; Gonella A; Quadri G; Longo G; Biondi-Zoccai G; Moretti C; Omedè P; Sciuto F; Gaita F; Sheiban I
    Am J Cardiol; 2011 Mar; 107(5):651-4. PubMed ID: 21195375
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term outcome after drug eluting stenting in patients with ST-segment elevation myocardial infarction: data from the REAL registry.
    Campo G; Saia F; Percoco G; Manari A; Santarelli A; Vignali L; Varani E; Benassi A; Sangiorgio P; Tarantino F; Magnavacchi P; De Palma R; Guastaroba P; Marzocchi A
    Int J Cardiol; 2010 Apr; 140(2):154-60. PubMed ID: 19056134
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Maintenance of long-term clinical benefit with sirolimus-eluting stents in patients with ST-segment elevation myocardial infarction 3-year results of the SESAMI (sirolimus-eluting stent versus bare-metal stent in acute myocardial infarction) trial.
    Violini R; Musto C; De Felice F; Nazzaro MS; Cifarelli A; Petitti T; Fiorilli R
    J Am Coll Cardiol; 2010 Feb; 55(8):810-4. PubMed ID: 20170821
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of outcomes between bare metal stents and drug-eluting stents for percutaneous revascularization of internal mammary grafts.
    Buch AN; Xue Z; Gevorkian N; Torguson R; Fournadjieva J; Deible R; Satler LF; Kent KM; Pichard AD; Waksman R
    Am J Cardiol; 2006 Sep; 98(6):722-4. PubMed ID: 16950170
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effectiveness and safety of drug-eluting stents in Ontario.
    Tu JV; Bowen J; Chiu M; Ko DT; Austin PC; He Y; Hopkins R; Tarride JE; Blackhouse G; Lazzam C; Cohen EA; Goeree R
    N Engl J Med; 2007 Oct; 357(14):1393-402. PubMed ID: 17914040
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Paclitaxel versus sirolimus stents in diabetic and nondiabetic patients.
    Chiu M; Ko DT; Austin PC; Cohen EA; Velianou JL; Goeree R; Blackhouse G; Tu JV
    Circ Cardiovasc Qual Outcomes; 2009 Mar; 2(2):96-107. PubMed ID: 20031821
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.